Your browser doesn't support javascript.
loading
Nasal Lymphoma with Low Mitotic Index in Three Cats Treated with Chlorambucil and Prednisolone.
Ng, Karen W L; Beatty, Julia A; Tse, May P Y; Giuliano, Antonio.
Afiliação
  • Ng KWL; CityU Veterinary Medical Centre, City University of Hong Kong, Hong Kong.
  • Beatty JA; Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine, City University of Hong Kong, Hong Kong.
  • Tse MPY; Centre for Animal Health and Welfare, City University of Hong Kong, Hong Kong.
  • Giuliano A; VDL Veterinary Diagnostic Laboratory, City University of Hong Kong, Hong Kong.
Vet Sci ; 9(9)2022 Sep 01.
Article em En | MEDLINE | ID: mdl-36136688
ABSTRACT
Lymphoma is the most common tumor of the nasal cavity in cats. Commonly used treatment modalities are radiotherapy and chemotherapy, or both. Typical chemotherapy protocols used in cats with nasal lymphoma are COP (cyclophosphamide, vincristine prednisolone) and CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone). Thus far, the use of single-agent chlorambucil in nasal lymphoma has been evaluated in a single case report. We report a case series of three cats with B cell nasal lymphoma, two cats with intermediate cell, and one large cell, all with a low mitotic index (MI) of less than 5 mitotic figures per ×400 field, treated with chlorambucil and prednisolone. Two of the cases achieved a long disease-free interval, while the one with the highest MI did not. Protocols using chlorambucil and prednisolone may have potential as a first-line therapy for feline nasal lymphoma cases with a very low mitotic index.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article